- call +1-201-465-4211
- email sales@mrinsights.biz
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
Scope of the Report:
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
In the last several years, global market of Asparaginase developed stably, with an average growth rate of 1.4%. In 2017, global revenue of Asparaginase is nearly 390 M USD; the actual production is about 590 K Units.
The worldwide market for Asparaginase is expected to grow at a CAGR of roughly 1.3% over the next five years, will reach 410 million US$ in 2024, from 380 million US$ in 2019, according to a new study.
This report focuses on the Asparaginase in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Jazz Pharmaceuticals
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Escherichia Coli
Erwinia Chrysanthemi
Pegylated
Market Segment by Applications, can be divided into
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Asparaginase product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Asparaginase, with price, sales, revenue and global market share of Asparaginase in 2017 and 2018.
Chapter 3, the Asparaginase competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Asparaginase breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Asparaginase market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Asparaginase sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Asparaginase Introduction
1.2 Market Analysis by Type
1.2.1 Escherichia Coli
1.2.2 Erwinia Chrysanthemi
1.2.3 Pegylated
1.3 Market Analysis by Applications
1.3.1 Acute Lymphoblastic Leukemia
1.3.2 Acute Myeloid Leukemia
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Jazz Pharmaceuticals
2.1.1 Business Overview
2.1.2 Asparaginase Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Jazz Pharmaceuticals Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Shire
2.2.1 Business Overview
2.2.2 Asparaginase Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shire Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Medac GmbH
2.3.1 Business Overview
2.3.2 Asparaginase Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Medac GmbH Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Kyowa Hakko Kirin
2.4.1 Business Overview
2.4.2 Asparaginase Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Kyowa Hakko Kirin Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Qianhong Bio-pharma
2.5.1 Business Overview
2.5.2 Asparaginase Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Qianhong Bio-pharma Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Taj Pharmaceuticals
2.6.1 Business Overview
2.6.2 Asparaginase Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Taj Pharmaceuticals Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Mingxing Pharma
2.7.1 Business Overview
2.7.2 Asparaginase Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mingxing Pharma Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 SL Pharma
2.8.1 Business Overview
2.8.2 Asparaginase Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 SL Pharma Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 United Biotech
2.9.1 Business Overview
2.9.2 Asparaginase Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 United Biotech Asparaginase Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Asparaginase Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Asparaginase Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Asparaginase Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Asparaginase Manufacturer Market Share in 2018
3.3.2 Top 6 Asparaginase Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Asparaginase Market Analysis by Regions
4.1 Global Asparaginase Sales, Revenue and Market Share by Regions
4.1.1 Global Asparaginase Sales and Market Share by Regions (2014-2019)
4.1.2 Global Asparaginase Revenue and Market Share by Regions (2014-2019)
4.2 North America Asparaginase Sales and Growth Rate (2014-2019)
4.3 Europe Asparaginase Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Asparaginase Sales and Growth Rate (2014-2019)
4.5 South America Asparaginase Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Asparaginase Sales and Growth Rate (2014-2019)
5 North America Asparaginase by Country
5.1 North America Asparaginase Sales, Revenue and Market Share by Country
5.1.1 North America Asparaginase Sales and Market Share by Country (2014-2019)
5.1.2 North America Asparaginase Revenue and Market Share by Country (2014-2019)
5.2 United States Asparaginase Sales and Growth Rate (2014-2019)
5.3 Canada Asparaginase Sales and Growth Rate (2014-2019)
5.4 Mexico Asparaginase Sales and Growth Rate (2014-2019)
6 Europe Asparaginase by Country
6.1 Europe Asparaginase Sales, Revenue and Market Share by Country
6.1.1 Europe Asparaginase Sales and Market Share by Country (2014-2019)
6.1.2 Europe Asparaginase Revenue and Market Share by Country (2014-2019)
6.2 Germany Asparaginase Sales and Growth Rate (2014-2019)
6.3 UK Asparaginase Sales and Growth Rate (2014-2019)
6.4 France Asparaginase Sales and Growth Rate (2014-2019)
6.5 Russia Asparaginase Sales and Growth Rate (2014-2019)
6.6 Italy Asparaginase Sales and Growth Rate (2014-2019)
7 Asia-Pacific Asparaginase by Country
7.1 Asia-Pacific Asparaginase Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Asparaginase Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Asparaginase Revenue and Market Share by Country (2014-2019)
7.2 China Asparaginase Sales and Growth Rate (2014-2019)
7.3 Japan Asparaginase Sales and Growth Rate (2014-2019)
7.4 Korea Asparaginase Sales and Growth Rate (2014-2019)
7.5 India Asparaginase Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Asparaginase Sales and Growth Rate (2014-2019)
8 South America Asparaginase by Country
8.1 South America Asparaginase Sales, Revenue and Market Share by Country
8.1.1 South America Asparaginase Sales and Market Share by Country (2014-2019)
8.1.2 South America Asparaginase Revenue and Market Share by Country (2014-2019)
8.2 Brazil Asparaginase Sales and Growth Rate (2014-2019)
8.3 Argentina Asparaginase Sales and Growth Rate (2014-2019)
8.4 Colombia Asparaginase Sales and Growth Rate (2014-2019)
9 Middle East and Africa Asparaginase by Countries
9.1 Middle East and Africa Asparaginase Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Asparaginase Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Asparaginase Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Asparaginase Sales and Growth Rate (2014-2019)
9.3 Turkey Asparaginase Sales and Growth Rate (2014-2019)
9.4 Egypt Asparaginase Sales and Growth Rate (2014-2019)
9.5 Nigeria Asparaginase Sales and Growth Rate (2014-2019)
9.6 South Africa Asparaginase Sales and Growth Rate (2014-2019)
10 Global Asparaginase Market Segment by Type
10.1 Global Asparaginase Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Asparaginase Sales and Market Share by Type (2014-2019)
10.1.2 Global Asparaginase Revenue and Market Share by Type (2014-2019)
10.2 Escherichia Coli Sales Growth and Price
10.2.1 Global Escherichia Coli Sales Growth (2014-2019)
10.2.2 Global Escherichia Coli Price (2014-2019)
10.3 Erwinia Chrysanthemi Sales Growth and Price
10.3.1 Global Erwinia Chrysanthemi Sales Growth (2014-2019)
10.3.2 Global Erwinia Chrysanthemi Price (2014-2019)
10.4 Pegylated Sales Growth and Price
10.4.1 Global Pegylated Sales Growth (2014-2019)
10.4.2 Global Pegylated Price (2014-2019)
11 Global Asparaginase Market Segment by Application
11.1 Global Asparaginase Sales Market Share by Application (2014-2019)
11.2 Acute Lymphoblastic Leukemia Sales Growth (2014-2019)
11.3 Acute Myeloid Leukemia Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Asparaginase Market Forecast (2019-2024)
12.1 Global Asparaginase Sales, Revenue and Growth Rate (2019-2024)
12.2 Asparaginase Market Forecast by Regions (2019-2024)
12.2.1 North America Asparaginase Market Forecast (2019-2024)
12.2.2 Europe Asparaginase Market Forecast (2019-2024)
12.2.3 Asia-Pacific Asparaginase Market Forecast (2019-2024)
12.2.4 South America Asparaginase Market Forecast (2019-2024)
12.2.5 Middle East and Africa Asparaginase Market Forecast (2019-2024)
12.3 Asparaginase Market Forecast by Type (2019-2024)
12.3.1 Global Asparaginase Sales Forecast by Type (2019-2024)
12.3.2 Global Asparaginase Market Share Forecast by Type (2019-2024)
12.4 Asparaginase Market Forecast by Application (2019-2024)
12.4.1 Global Asparaginase Sales Forecast by Application (2019-2024)
12.4.2 Global Asparaginase Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Asparaginase Picture
Table Product Specifications of Asparaginase
Figure Global Sales Market Share of Asparaginase by Types in 2018
Table Asparaginase T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
